Literature DB >> 15609119

Overview of economic evaluation of positron-emission tomography.

A Müller1, D Stratmann-Schöne, T Klose, R Leidl.   

Abstract

Since the 1990s positron-emission tomography (PET) in Germany has been used increasingly in clinical diagnostics in the areas of oncology, cardiology, and neurology/ psychiatry. As the use of PET requires a complex and expensive infrastructure, analysis of the cost-effectiveness of PET compared to common diagnostic methods is becoming increasingly important. This contribution summarizes and discusses the results of a health technology assessment report on the cost-effectiveness of PET.

Year:  2002        PMID: 15609119     DOI: 10.1007/s10198-001-0084-3

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  2 in total

1.  An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography.

Authors:  Paolo Pertile
Journal:  Int J Health Care Finance Econ       Date:  2009-01-18

2.  Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review.

Authors:  Salvatore Annunziata; Carmelo Caldarella; Giorgio Treglia
Journal:  World J Radiol       Date:  2014-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.